Discovery of anti-inflammatory β-acids featuring an unusual 5/7/5 tricyclic skeleton via targeting the TLR4/MyD88 signaling pathway
Bioorganic Chemistry · 2026
DOI: 10.1016/j.bioorg.2026.110415 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Kang Ding und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medical Sciences & Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, P. R. China. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Myeloid Differentiation Factor 88, Anti-Inflammatory Agents, Non-Steroidal, Drug Discovery. Die Arbeit nennt 15 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences, China-Japan Friendship Hospital, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Five pairs of previously undescribed β-acid enantiomers, (±)-humulunes A-E (1-5), were isolated from Humulus lupulus L. These compounds feature an unusual 5/7/5 tricyclic ring skeleton bearing multiple stereocenters. Their structures were elucidated through comprehensive spectroscopic analysis, including calculated NMR and electronic circular dichroism (ECD), as well as single-crystal X-ray diffraction. Among them, compounds (+)-3, (-)-3, and (+)-4 exhibited significant anti-inflammatory activity in LPS-induced RAW 264.7 cells. Furthermore, compound (-)-3 was found to inhibit cell apoptosis and reactive oxygen species (ROS) production, modulate macrophage polarization, and suppress the TLR4/MyD88 signaling pathway. Molecular docking, molecular dynamics simulation, and cellular thermal shift assay (CETSA) confirmed the direct and stable binding of (-)-3 to TLR4 protein, which may exert anti-inflammatory effects by blocking the activation of the TLR4/MyD88 signaling pathway, providing a reference for the development of anti-inflammatory therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Medical Sciences & Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, P. R. China.
- China-Japan Friendship Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100029, P. R. China.
- School of Life Sciences & School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, P. R. China.
- School of Life Sciences & School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, P. R. China. Electronic address: xjkbucm@163.com.
- Institute of Clinical Medical Sciences & Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, P. R. China. Electronic address: 15010297582@126.com.
- Institute of Clinical Medical Sciences & Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, P. R. China. Electronic address: cpuzwk@163.com.
Förderung
- Chinese Academy of Medical Sciences
- China-Japan Friendship Hospital
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Ding, K., Zhou, F. L., Shi, Y. J., Sha, Z. H., Wang, L. J., Zhang, J., Bai, M. L., Li, Z. Z., Xu, J. K., He, J., & Zhang, W. K. (2026). Discovery of anti-inflammatory β-acids featuring an unusual 5/7/5 tricyclic skeleton via targeting the TLR4/MyD88 signaling pathway. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.110415
Vancouver
Ding K, Zhou FL, Shi YJ, Sha ZH, Wang LJ, Zhang J, et al. Discovery of anti-inflammatory β-acids featuring an unusual 5/7/5 tricyclic skeleton via targeting the TLR4/MyD88 signaling pathway. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.110415
BibTeX
@article{Ding2026,
author = {Ding, Kang and Zhou, Fu-Lin and Shi, Yan-Jing and Sha, Zi-Hao and Wang, Li-Jie and Zhang, Jia and Bai, Mao-Li and Li, Zhou-Zi-Qi and Xu, Jie-Kun and He, Jun and Zhang, Wei-Ku},
title = {Discovery of anti-inflammatory β-acids featuring an unusual 5/7/5 tricyclic skeleton via targeting the TLR4/MyD88 signaling pathway},
journal = {Bioorganic Chemistry},
year = {2026},
doi = {10.1016/j.bioorg.2026.110415}
}
EUVIMED